K Health raised $50M in equity funding led by Claure Group and Pablo Legorreta to improve access to high-quality primary care with AI technology.

Jul 01, 2024•over 1 year ago

Amount Raised

$50 Million

New YorkMedicalHealth Care

Investors

Atreides Management, LpValor Equity PartnersMangrove Capital PartnersPablo LegorretaClaure Group

Description

K Health, the leading AI Primary Care platform, has announced a $50M equity funding round led by Claure Group, with participation from investors including Pablo Legorreta, founder and CEO of Royalty Pharma, and existing investors Mangrove Capital Partners, Valor Equity Partners, and Atreides Management, LP. The funding will be used to improve access to high-quality primary care through AI technology, addressing the challenges of physician supply and fragmentation from point solutions.

Company Information

Company

K Health

Location

New York, New York, United States

About

K Health is the AI-driven Primary Care company on a mission to provide access to high-quality medical care at scale. Its 24/7 virtual primary care solution is available to millions of people in the U.S. through leading health systems and insurers, as well as through a direct-to-consumer mobile app. K Health’s platform includes a medical chat and AI predictive models based on large datasets to help physicians optimize diagnosis and treatment, and focus on patient care. K Health is backed by leading investors including Valor Equity Partners, Mangrove Capital Partners, GGV Capital, 14W, Comcast Ventures, Lerer Hippeau, Primary Venture Partners, and PICO Capital Partners.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends